Ledger.Open graph →
SEC Form D · filed August 29, 2019

Chinook Therapeutics U.S., Inc

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Ron · Berkeley, CADirectorGregorio Schneider · Berkeley, CAExec · DirectorStephen Plume · Berkeley, CADirectorSam Hall · New York, NYDirectorLyle Berkowitz · Chicago, ILDirectorMark Bakken · Madison, WIDirectorDerek Kim · CHEYENNE, WYExec · DirectorSrini Akkaraju · Waltham, MADirectorSam Hall · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗